NASDAQ
Rockwell Medical, Inc. (RMTI)
♥ 578 Thanks from members
Rockwell Medical (RMTI) demonstrates steady financial improvement in Q2 2026, featuring 11% revenue growth to $17.8 million, margin expansion via automation, and positive operating cash flow, prompting management to reaffirm its full-year guidance of $70M–$75M in net sales.